<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01859247</url>
  </required_header>
  <id_info>
    <org_study_id>UNM 657</org_study_id>
    <secondary_id>U54NS065701</secondary_id>
    <nct_id>NCT01859247</nct_id>
  </id_info>
  <brief_title>Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study</brief_title>
  <official_title>Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dystonia Coalition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this application is to therapeutically target the dysfunctional
      premotor-motor interaction in dystonia—and to provide a focused treatment of specific
      anatomical networks in order to reduce side effects and to improve symptom control over
      conventional therapies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose using repetitive transcranial magnetic stimulation (rTMS) over distinct premotor
      areas in patients with cervical dystonia (CD) with the goal of improving symptoms and
      reducing unwanted side effects. The knowledge gained in this proposed research will identify
      a specific premotor area to be targeted with rTMS that is expected to result in a novel
      intervention that could enhance or replace current treatments for CD. rTMS could be included
      as an adjunct treatment to botulinum toxin that could sustain treatment effect and decrease
      the frequency of re-injection, potentially resulting in cost savings without a decrease in
      symptom control. In addition to medical cost reduction, improved quality of life could be
      expected with the successful development of therapies that extend dystonia symptom control.
      rTMs has been FDA-approved for the treatment of depression and our proposal uses an even
      lower stimulation rate, suggesting continued use within clearly safe parameters. Successful
      completion of this research could lead to rapid adoption of this therapeutic modality.

      We will test the hypothesis that rTMS of a distinct premotor site will provide more effective
      treatment of CD than non-specific activation of the entire premotor region. This will be done
      by performing a randomized, observer-blinded exploratory pilot study to determine the optimal
      site of rTMS over various sites of the premotor and motor cortex to improve the symptoms of
      cervical dystonia. Completion of this aim should lead to development of targeted TMS therapy
      for CD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)</measure>
    <time_frame>Change from baseline pre-intervention TWSTRS score to post-intervention within 1 hour of treatment</time_frame>
    <description>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dorsal Premotor-motor Inhibition (dPMI)</measure>
    <time_frame>Change from baseline dPMI to post-intervention within 1 hour of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Measure of Patient Rating of Symptoms and Tolerability</measure>
    <time_frame>Assessment completed immediately after rTMS treatment session</time_frame>
    <description>This measure will confirm the intervention tolerability by the patient. He/she scored the tolerability from 0-10, 0 being &quot;completely tolerable&quot; and 10 &quot;completely intolerable.&quot;</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Cervical Dystonia</condition>
  <condition>Spasmodic Torticollis</condition>
  <arm_group>
    <arm_group_label>Dorsal Premotor rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary motor cortex rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supplemental Motor Area rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anterior Cingulate rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>0.2 Hz rTMS for 15 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <arm_group_label>Dorsal Premotor rTMS</arm_group_label>
    <arm_group_label>Primary motor cortex rTMS</arm_group_label>
    <arm_group_label>Supplemental Motor Area rTMS</arm_group_label>
    <arm_group_label>Anterior Cingulate rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of idiopathic cervical dystonia

          -  Age 18 years or older

          -  Normal findings in the medical history, physical and neurological examination, except
             for dystonia

          -  Last treatment with botulinum toxin more than two months ago

        Exclusion Criteria:

          -  History of seizure disorder

          -  Pregnancy- a pregnancy test will be performed for women of childbearing potential

          -  History of any other neurological disorders or conditions requiring the use of
             anti-depressants that are known to increase seizure threshold, neuroleptic medication,
             anticholinergic drugs and muscle relaxants

          -  History of neuroleptic medications/ prior use of neuroleptics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Pirio Richardson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H.A. Jinnah, MD</last_name>
    <role>Study Director</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://rarediseasesnetwork.epi.usf.edu/dystonia/</url>
    <description>Dystonia Coalition</description>
  </link>
  <reference>
    <citation>Beck S, Houdayer E, Richardson SP, Hallett M. The role of inhibition from the left dorsal premotor cortex in right-sided focal hand dystonia. Brain Stimul. 2009 Oct;2(4):208-14. doi: 10.1016/j.brs.2009.03.004. Epub 2009 May 3.</citation>
    <PMID>20633420</PMID>
  </reference>
  <reference>
    <citation>Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci. 2008 Mar;9(3):222-34. doi: 10.1038/nrn2337. Review.</citation>
    <PMID>18285800</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, Fénelon G, Ménard-Lefaucheur I, Wendling S, Nguyen JP. Low-frequency repetitive TMS of premotor cortex can reduce painful axial spasms in generalized secondary dystonia: a pilot study of three patients. Neurophysiol Clin. 2004 Oct;34(3-4):141-5.</citation>
    <PMID>15501683</PMID>
  </reference>
  <reference>
    <citation>Murase N, Rothwell JC, Kaji R, Urushihara R, Nakamura K, Murayama N, Igasaki T, Sakata-Igasaki M, Mima T, Ikeda A, Shibasaki H. Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain. 2005 Jan;128(Pt 1):104-15. Epub 2004 Oct 13.</citation>
    <PMID>15483042</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2013</study_first_submitted>
  <study_first_submitted_qc>May 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2013</study_first_posted>
  <results_first_submitted>January 8, 2016</results_first_submitted>
  <results_first_submitted_qc>June 16, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 28, 2016</results_first_posted>
  <last_update_submitted>June 16, 2016</last_update_submitted>
  <last_update_submitted_qc>June 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of New Mexico</investigator_affiliation>
    <investigator_full_name>Sarah Pirio Richardson</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>cervical dystonia</keyword>
  <keyword>torticollis</keyword>
  <keyword>rTMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
    <mesh_term>Torticollis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Subject 1</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Primary Motor Cortex Supplemental Motor Area Sham Dorsal Premotor Cortex Anterior Cingulate Cortex</description>
        </group>
        <group group_id="P2">
          <title>Subject 2</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Primary Motor Cortex Dorsal Premotor Cortex Sham Supplemental Motor Area</description>
        </group>
        <group group_id="P3">
          <title>Subject 3</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Dorsal Premotor Cortex Supplemental Motor Area Sham Primary Motor Cortex Anterior Cingulate Cortex</description>
        </group>
        <group group_id="P4">
          <title>Subject 4</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Supplemental Motor Area Sham Anterior Cingulate Cortex Primary Motor Cortex Dorsal Premotor Cortex</description>
        </group>
        <group group_id="P5">
          <title>Subject 5</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Sham Dorsal Premotor Cortex Primary Motor Cortex Supplemental Motor Area Anterior Cingulate Cortex</description>
        </group>
        <group group_id="P6">
          <title>Subject 6</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Dorsal Premotor Cortex Supplemental Motor Area Sham Primary Motor Cortex</description>
        </group>
        <group group_id="P7">
          <title>Subject 7</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Sham Primary Motor Cortex Dorsal Premotor Cortex Anterior Cingulate Cortex Supplemental Motor Area</description>
        </group>
        <group group_id="P8">
          <title>Subject 8</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Supplemental Motor Area Primary Motor Cortex Sham Dorsal Premotor Cortex</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Subject 1</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Primary Motor Cortex Supplemental Motor Area Sham Dorsal Premotor Cortex Anterior Cingulate Cortex</description>
        </group>
        <group group_id="B2">
          <title>Subject 2</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Primary Motor Cortex Dorsal Premotor Cortex Sham Supplemental Motor Area</description>
        </group>
        <group group_id="B3">
          <title>Subject 3</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Dorsal Premotor Cortex Supplemental Motor Area Sham Primary Motor Cortex Anterior Cingulate Cortex</description>
        </group>
        <group group_id="B4">
          <title>Subject 4</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Supplemental Motor Area Sham Anterior Cingulate Cortex Primary Motor Cortex Dorsal Premotor Cortex</description>
        </group>
        <group group_id="B5">
          <title>Subject 5</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Sham Dorsal Premotor Cortex Primary Motor Cortex Supplemental Motor Area Anterior Cingulate Cortex</description>
        </group>
        <group group_id="B6">
          <title>Subject 6</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Dorsal Premotor Cortex Supplemental Motor Area Sham Primary Motor Cortex</description>
        </group>
        <group group_id="B7">
          <title>Subject 7</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Sham Primary Motor Cortex Dorsal Premotor Cortex Anterior Cingulate Cortex Supplemental Motor Area</description>
        </group>
        <group group_id="B8">
          <title>Subject 8</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Supplemental Motor Area Primary Motor Cortex Sham Dorsal Premotor Cortex</description>
        </group>
        <group group_id="B9">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="1"/>
            <count group_id="B4" value="1"/>
            <count group_id="B5" value="1"/>
            <count group_id="B6" value="1"/>
            <count group_id="B7" value="1"/>
            <count group_id="B8" value="1"/>
            <count group_id="B9" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" lower_limit="33" upper_limit="33"/>
                    <measurement group_id="B2" value="60" lower_limit="60" upper_limit="60"/>
                    <measurement group_id="B3" value="67" lower_limit="67" upper_limit="67"/>
                    <measurement group_id="B4" value="31" lower_limit="31" upper_limit="31"/>
                    <measurement group_id="B5" value="55" lower_limit="55" upper_limit="55"/>
                    <measurement group_id="B6" value="41" lower_limit="41" upper_limit="41"/>
                    <measurement group_id="B7" value="65" lower_limit="65" upper_limit="65"/>
                    <measurement group_id="B8" value="72" lower_limit="72" upper_limit="72"/>
                    <measurement group_id="B9" value="53" lower_limit="31" upper_limit="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>TWSTRS Severity (Toronto Western Spasmodic Torticollis Rating Scale)</title>
          <description>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20" lower_limit="20" upper_limit="20"/>
                    <measurement group_id="B2" value="9" lower_limit="9" upper_limit="9"/>
                    <measurement group_id="B3" value="8" lower_limit="8" upper_limit="8"/>
                    <measurement group_id="B4" value="14" lower_limit="14" upper_limit="14"/>
                    <measurement group_id="B5" value="21" lower_limit="21" upper_limit="21"/>
                    <measurement group_id="B6" value="20" lower_limit="20" upper_limit="20"/>
                    <measurement group_id="B7" value="12" lower_limit="12" upper_limit="12"/>
                    <measurement group_id="B8" value="16" lower_limit="16" upper_limit="16"/>
                    <measurement group_id="B9" value="15" lower_limit="8" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dorsal Premotor-Motor Cortical Inhibition (DPMi)</title>
          <units>Percentage</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="213" lower_limit="213" upper_limit="213"/>
                    <measurement group_id="B2" value="127.50" lower_limit="127.50" upper_limit="127.50"/>
                    <measurement group_id="B3" value="68.10" lower_limit="68.10" upper_limit="68.10"/>
                    <measurement group_id="B4" value="71.60" lower_limit="71.60" upper_limit="71.60"/>
                    <measurement group_id="B5" value="NA">Pre-DPMI not obtained</measurement>
                    <measurement group_id="B6" value="NA">Pre-DPMI not obtained</measurement>
                    <measurement group_id="B7" value="67.80" lower_limit="67.80" upper_limit="67.80"/>
                    <measurement group_id="B8" value="72.30" lower_limit="72.30" upper_limit="72.30"/>
                    <measurement group_id="B9" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cortical Silent Period (CSP)</title>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="169.10" lower_limit="169.10" upper_limit="169.10"/>
                    <measurement group_id="B2" value="153.70" lower_limit="153.70" upper_limit="153.70"/>
                    <measurement group_id="B3" value="133.28" lower_limit="133.28" upper_limit="133.28"/>
                    <measurement group_id="B4" value="78.10" lower_limit="78.10" upper_limit="78.10"/>
                    <measurement group_id="B5" value="136.92" lower_limit="136.92" upper_limit="136.92"/>
                    <measurement group_id="B6" value="76.24" lower_limit="76.24" upper_limit="76.24"/>
                    <measurement group_id="B7" value="113.16" lower_limit="113.16" upper_limit="113.16"/>
                    <measurement group_id="B8" value="99.76" lower_limit="99.76" upper_limit="99.76"/>
                    <measurement group_id="B9" value="105.03" lower_limit="76.24" upper_limit="169.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)</title>
        <description>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).</description>
        <time_frame>Change from baseline pre-intervention TWSTRS score to post-intervention within 1 hour of treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Primary Motor Cortex rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Anterior Cingulate rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
          <group group_id="O3">
            <title>Dorsal Premotor rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
          <group group_id="O4">
            <title>Supplemental Motor Area rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
          <group group_id="O5">
            <title>Sham rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
        </group_list>
        <measure>
          <title>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)</title>
          <description>Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) was used to assess severity of disease. The score for this section ranges from 0 (absence of severity) to 35 (maximum severity).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="4.8"/>
                    <measurement group_id="O2" value="0.25" spread="1.7"/>
                    <measurement group_id="O3" value="-2.9" spread="3.4"/>
                    <measurement group_id="O4" value="-1.5" spread="3.2"/>
                    <measurement group_id="O5" value="-0.5" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dorsal Premotor-motor Inhibition (dPMI)</title>
        <time_frame>Change from baseline dPMI to post-intervention within 1 hour of treatment</time_frame>
        <population>two subjects did not have dPMI measured</population>
        <group_list>
          <group group_id="O1">
            <title>Primary Motor Cortex rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Anterior Cingulate rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
          <group group_id="O3">
            <title>Dorsal Premotor rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
          <group group_id="O4">
            <title>Supplemental Motor Area rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
          <group group_id="O5">
            <title>Sham rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Dorsal Premotor-motor Inhibition (dPMI)</title>
          <population>two subjects did not have dPMI measured</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.50" spread="40.5"/>
                    <measurement group_id="O2" value="2.10" spread="24.5"/>
                    <measurement group_id="O3" value="21.08" spread="42.5"/>
                    <measurement group_id="O4" value="32.21" spread="53.5"/>
                    <measurement group_id="O5" value="19.71" spread="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Measure of Patient Rating of Symptoms and Tolerability</title>
        <description>This measure will confirm the intervention tolerability by the patient. He/she scored the tolerability from 0-10, 0 being &quot;completely tolerable&quot; and 10 &quot;completely intolerable.&quot;</description>
        <time_frame>Assessment completed immediately after rTMS treatment session</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Primary Motor Cortex rTMS</title>
            <description>0.2Hz for 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Anterior Cingulate rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
          <group group_id="O3">
            <title>Dorsal Premotor rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
          <group group_id="O4">
            <title>Supplemental Motor Area rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
          <group group_id="O5">
            <title>Sham rTMS</title>
            <description>0.2Hz for 15 minutes:</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Measure of Patient Rating of Symptoms and Tolerability</title>
          <description>This measure will confirm the intervention tolerability by the patient. He/she scored the tolerability from 0-10, 0 being &quot;completely tolerable&quot; and 10 &quot;completely intolerable.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="1.8"/>
                    <measurement group_id="O2" value="1.6" spread="2.8"/>
                    <measurement group_id="O3" value="1.5" spread="2.7"/>
                    <measurement group_id="O4" value="0.9" spread="1.1"/>
                    <measurement group_id="O5" value="0.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Subject 1</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Primary Motor Cortex Supplemental Motor Area Sham Dorsal Premotor Cortex Anterior Cingulate Cortex</description>
        </group>
        <group group_id="E2">
          <title>Subject 2</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Primary Motor Cortex Dorsal Premotor Cortex Sham Supplemental Motor Area</description>
        </group>
        <group group_id="E3">
          <title>Subject 3</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Dorsal Premotor Cortex Supplemental Motor Area Sham Primary Motor Cortex Anterior Cingulate Cortex</description>
        </group>
        <group group_id="E4">
          <title>Subject 4</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Supplemental Motor Area Sham Anterior Cingulate Cortex Primary Motor Cortex Dorsal Premotor Cortex</description>
        </group>
        <group group_id="E5">
          <title>Subject 5</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Sham Dorsal Premotor Cortex Primary Motor Cortex Supplemental Motor Area Anterior Cingulate Cortex</description>
        </group>
        <group group_id="E6">
          <title>Subject 6</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Dorsal Premotor Cortex Supplemental Motor Area Sham Primary Motor Cortex</description>
        </group>
        <group group_id="E7">
          <title>Subject 7</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Sham Primary Motor Cortex Dorsal Premotor Cortex Anterior Cingulate Cortex Supplemental Motor Area</description>
        </group>
        <group group_id="E8">
          <title>Subject 8</title>
          <description>Received rTMS intervention in the following order, each at 0.2Hz for 15 minutes:
Anterior Cingulate Cortex Supplemental Motor Area Primary Motor Cortex Sham Dorsal Premotor Cortex</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Sarah Pirio Richardson, MD</name_or_title>
      <organization>The University of New Mexico Health Sciences Center</organization>
      <phone>505-272-3342</phone>
      <email>spiriorichardson@salud.unm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

